Your session is about to expire
← Back to Search
Preference Elicitation tool for Carpal Tunnel Syndrome
N/A
Waitlist Available
Led By Robin N Kamal, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinical diagnosis of carpal tunnel syndrome
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after using tool
Awards & highlights
Study Summary
This trial will compare two groups of 150 patients each, one treated for carpal tunnel syndrome with a new tool and one treated with standard care. The goal is to see if the new tool decreases patients' decisional conflict.
Eligible Conditions
- Carpal Tunnel Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have been diagnosed with carpal tunnel syndrome.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after using tool
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after using tool
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decisional Conflict Scale
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Patients will use a preference elicitation tool to determine their preferences for diagnosis and treatment of CTS
Group II: ControlActive Control1 Intervention
None- normal care
Find a Location
Who is running the clinical trial?
Harvard UniversityOTHER
229 Previous Clinical Trials
474,560 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,878 Total Patients Enrolled
5 Trials studying Carpal Tunnel Syndrome
798 Patients Enrolled for Carpal Tunnel Syndrome
Duke UniversityOTHER
2,351 Previous Clinical Trials
3,409,497 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with carpal tunnel syndrome.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any ongoing recruitment opportunities for this research endeavor?
"The clinicaltrials.gov registry shows that this study, which was first announced on March 1st 2021 and last updated four months ago, is not presently recruiting patients. However, there are currently 1404 other trials actively searching for participants to enroll in their research programs."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger